glp 1 boom GLP-1 nudges cannabis dispensaries to rethink offerings Beyond the GLP-1 Boom: How

Greenes advice, he went to a doctor for a prescription

GLP-1 Drug Market Size, Share, Growth, and Industry Analysis, By Types (Short-acting GLP-1 Drug,Long-acting GLP-1 Drug), By Applications (Obesity,Type 2 Diabetes (T2DM),Cardiovascular and Cerebrovascular Diseases (CVD),Non-alcoholic Steatohepatitis (NASH),Alzheimer's Disease (AD)) , and Regional Insights and Forecast to 2035 Last Updated: 23-March-2026 Base Year: 2025 Historical Data: 2021-2024 Region: Global Report ID: GGI124388 SKU ID: 30248947 Pages: 113 GLP-1 Drug Market Size The Global GLP-1 Drug Market is expanding rapidly, with the market size valued at USD 37.57 billion in 2025 and projected to reach USD 47.6 billion in 2026, further advancing to USD 60.31 billion in 2027 and USD 400.5 billion by 2035, exhibiting a CAGR of 26.7% during the forecast period

Formulated for human consumption

From there, they can recommend evidence-based treatments, including: physical therapy hormone replacement therapy (HRT) exercise sleep habit advice anti-inflammatory strategies pain management This is a much better plan than a self-diagnosis and a peptide

But when it comes to breastfeeding, the risk if any to a new mom or her baby while shes taking one of the drugs is less known